PAUL D'AMBROSIO: Open Payments
NPI 1033194048 · CONCORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,690 in 85 payments from 22 companies in 2025. Trend: 2023 $2,178 · 2024 $2,206 · 2025 $1,690
Food & beverage: $1,690
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 22 | $377 |
| TOLMAR, INC. | 11 | $189 |
| ABBVIE INC. | 7 | $152 |
| Merck Sharp & Dohme LLC | 8 | $145 |
| Exact Sciences Corporation | 7 | $135 |
| AstraZeneca Pharmaceuticals LP | 5 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $79 |
| Novo Nordisk Inc | 4 | $76 |
| Eisai Inc. | 2 | $55 |
| Corcept Therapeutics | 1 | $45 |
Products named: ELIQUIS, JATENZO, PREVNAR 20, UBRELVY, Wegovy, NURTEC ODT, GARDASIL 9, Leqembi.
Industry payments across MA — which companies pay providers there.
